Strategic Swiss Partners – Evax AG: An Associated Swiss Life Sciences & Innovation Project
Ingelheim-Germany , Thurgau- Switzerland | 14 August 2026
Strategic Swiss Partners AG (SSP) is pleased to highlight the acquisition of Evax AG by Boehringer Ingelheim, reflecting the growing international recognition of Switzerland as a leading hub for biotechnology, scientific research and innovation.
Evax AG is a Swiss biotechnology company developing therapeutic vaccines for equine health. Founded more than a decade ago at the University of Zurich , Evax focuses on addressing allergic skin diseases in horses through innovative virus-like particle technology.
The acquisition of Evax further strengthens Boehringer Ingelheim’s strategy to develop preventive and therapeutic solutions for animal health, including chronic conditions in pets and allergy-related disorders in horses.
The transaction demonstrates the strength of Switzerland’s biotechnology ecosystem, where **university-driven research, entrepreneurial innovation and international strategic investment** come together to advance technologies with significant global commercial potential and address important unmet needs in animal health.
For SSP, the Evax transaction is representative of its broader commitment to **supporting strategic partnerships, facilitating international market access and promoting Swiss innovation with global potential**. SSP continues to connect Swiss companies, innovative technologies and strategic partners with international markets and opportunities.
The transaction also highlights the potential for Swiss-founded biotechnology companies to progress from **academic and entrepreneurial origins to international commercialisation** through partnerships with leading global life sciences organisations.
Official Sources
Evax AG – Evax becomes part of Boehringer Ingelheim Animal Health
Boehringer Ingelheim – Acquisition of Evax AG
Strategic Swiss Partners AG (SSP) highlights selected Swiss innovation, life sciences and technology projects that demonstrate Switzerland’s potential as a platform for international partnerships, investment and market access.
For further info:
Info@strategicswisspartrners.com
